Abstract
Phenotypic heterogeneity in early language, intellectual, motor, and adaptive functioning (LIMA) features are amongst the most striking features that distinguish different types of autistic individuals. Yet the current diagnostic criteria uses a single label of autism and implicitly emphasizes what individuals have in common as core social-communicative and restricted repetitive behavior difficulties. Subtype labels based on the non-core LIMA features may help to more meaningfully distinguish types of autisms with differing developmental paths and differential underlying biology. Using relatively large (n=615) publicly available data from early developing (24-68 months) standardized clinical tests tapping LIMA features, we show that stability-based relative cluster validation analysis can identify two robust and replicable clusters in the autism population with high levels of generalization accuracy (98%). These clusters can be described as Type I versus Type II autisms differentiated by relatively high versus low scores on LIMA features. These two types of autisms are also distinguished by different developmental trajectories over the first decade of life. Finally, these two types of autisms reveal striking differences in functional and structural neuroimaging phenotypes and their relationships with gene expression. This work emphasizes the potential importance of stratifying autism by a Type I versus Type II distinction focused on LIMA features and which may be of high prognostic and biological significance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was supported by funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme under grant agreement No 755816 (AUTISMS) (ERC Starting Grant to MVL) and under the European Union's Horizon Europe research and innovation programme under grant agreement No 101087263 (AUTISMS-3D) (ERC Consolidator Grant to MVL). Neuroimaging data and longitudinal phenotypic data from UCSD ACE was collected with the support of the following grants: NIMH R01-MH080134 (KP), NIMH R01-MH104446 (KP), NFAR grant (KP), NIMH Autism Center of Excellence grant P50-MH081755 (EC, KP), NIMH R01-MH036840 (EC), NIMH R01-MH110558 (EC), NIMH U01-MH108898 (EC), NIDCD R01-DC016385 (EC, KP, LE, MVL), CDMRP AR130409 (EC), and the Simons Foundation 176540 (EC).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Institutional Review Board at University of California, San Diego.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data utilized in this work can be found in the National Institute of Mental Health Data Archive (NDA; https://nda.nih.gov). For the UCSD ACE data, the data are available on NDA through collection IDs 9, 2466, 2968, 2290 and 2115.
